PKCPY yields 2.72% · PFE yields 6.13%● Live data
📍 PKCPY pulled ahead of the other in Year 1
Combined, PKCPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PKCPY + PFE for your $10,000?
PT AKR Corporindo Tbk, a logistics and supply chain company, engages in distribution and trading of petroleum and basic chemical products primarily in Indonesia. It operates through four segments: Trading and Distribution, Logistics Services, Manufacturing, and Industrial Estate. The Trading and Distribution segment is involved in the distribution of petroleum products and various basic chemicals, such as caustic soda, sodium sulphate, PVC resins, and soda ash. The Logistics Services segment offers various logistics services, including rental of storage tanks and warehouses, bagging, port handling, and transportation services primarily for liquid and solid chemical, and petroleum products. The Manufacturing segment produces and sells adhesive materials. The Industrial Estate segment leases and sells industrial and port estates. The company was formerly known as PT Aneka Kimia Raya Tbk and changed its name to PT AKR Corporindo Tbk in September 2004. The company was incorporated in 1977 and is headquartered in Jakarta, Indonesia. PT AKR Corporindo Tbk is a subsidiary of PT Arthakencana Rayatama.
Full PKCPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.